Teva Pharmaceuticals @TevaUSA
In a new study in @BMJOpen, our partners at @ArnholdInst found 61.5% of patients with Medicaid insurance in NYC between 2012 and 2014 had #MultipleChronicConditions (MCC). Learn more about the research and Teva’s efforts to address MCC. @MountSinaiNYC https://t.co/PWpovtNYXn https://t.co/xLZNqvLGM9 — PolitiTweet.org